GR3036407T3 - Encapsulated medicine - Google Patents

Encapsulated medicine

Info

Publication number
GR3036407T3
GR3036407T3 GR20010401130T GR20010401130T GR3036407T3 GR 3036407 T3 GR3036407 T3 GR 3036407T3 GR 20010401130 T GR20010401130 T GR 20010401130T GR 20010401130 T GR20010401130 T GR 20010401130T GR 3036407 T3 GR3036407 T3 GR 3036407T3
Authority
GR
Greece
Prior art keywords
pct
date jan
sec
insoluble compound
practically insoluble
Prior art date
Application number
GR20010401130T
Other languages
English (en)
Inventor
Takehisa Hata
Fumio Shimojo
Kazutake Kado
Kyoko Ishii
Seiji Sawai
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of GR3036407T3 publication Critical patent/GR3036407T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
GR20010401130T 1993-06-30 2001-08-17 Encapsulated medicine GR3036407T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP16098393 1993-06-30
PCT/JP1994/001043 WO1995001166A1 (en) 1993-06-30 1994-06-28 Encapsulated medicine

Publications (1)

Publication Number Publication Date
GR3036407T3 true GR3036407T3 (en) 2001-11-30

Family

ID=15726345

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20010401130T GR3036407T3 (en) 1993-06-30 2001-08-17 Encapsulated medicine

Country Status (15)

Country Link
US (1) US5683716A (el)
EP (1) EP0706380B1 (el)
JP (1) JPH09501150A (el)
KR (1) KR960703335A (el)
CN (1) CN1087933C (el)
AT (1) ATE204163T1 (el)
AU (1) AU682192B2 (el)
CA (1) CA2165789A1 (el)
DE (1) DE69427981T2 (el)
DK (1) DK0706380T3 (el)
ES (1) ES2161768T3 (el)
GR (1) GR3036407T3 (el)
PT (1) PT706380E (el)
TW (1) TW360543B (el)
WO (1) WO1995001166A1 (el)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6024980A (en) * 1996-06-28 2000-02-15 Mcneil-Ppc, Inc. Multiphase soft gelatin dosage form
US5919481A (en) * 1996-06-28 1999-07-06 Ncneil-Ppc, Inc. Fill material for soft gelatin pharmaceutical dosage form
US6555139B2 (en) 1999-06-28 2003-04-29 Wockhardt Europe Limited Preparation of micron-size pharmaceutical particles by microfluidization
WO2001060353A1 (fr) * 2000-02-21 2001-08-23 Fujisawa Pharmaceutical Co., Ltd. Preparation liquide a absorbabilite amelioree
US6635277B2 (en) 2000-04-12 2003-10-21 Wockhardt Limited Composition for pulsatile delivery of diltiazem and process of manufacture
WO2002094173A2 (en) * 2001-05-22 2002-11-28 Euro-Celtique Tamper resistant oral dosage form
US20030077378A1 (en) * 2001-10-22 2003-04-24 Lou Wen Chin Hydroxypropyl cellulose encapsulation material
NZ584729A (en) * 2007-10-05 2012-12-21 Alzheimer S Inst Of America Inc Method for reducing amyloid deposition, amyloid neurotoxicity, and microgliosis with (-)-nilvadipine enantiomer
JP5750278B2 (ja) * 2011-02-28 2015-07-15 東洋カプセル株式会社 カンデサルタンシレキセチルのカプセル充填用組成物
WO2014010008A1 (ja) * 2012-07-09 2014-01-16 東洋カプセル株式会社 カンデサルタンシレキセチルのカプセル充填用組成物
US11491088B2 (en) 2012-11-06 2022-11-08 CoLabs International Corporation Compositions containing a capsule with a moisturizing agent
US11724134B2 (en) 2012-11-06 2023-08-15 CoLabs International Corporation Compositions containing a cellulose derived capsule with a sunscreen active agent
US10322301B2 (en) 2012-11-06 2019-06-18 CoLabs International Corporation Compositions containing a cellulose derived capsule with a sunscreen active agent
US11690793B2 (en) 2012-11-06 2023-07-04 Colabs Int'l Corp. Composition containing a cellulose derived capsule with a sunscreen
US11707421B2 (en) 2012-11-06 2023-07-25 Colabs Int'l Corp. Compositions containing a flexible derived capsule with an active agent
JP2015536985A (ja) 2012-11-06 2015-12-24 コラブス インターナショナル コーポレーション 日焼け止めを含むセルロース由来カプセル含有組成物
EP3813786A4 (en) 2018-06-27 2022-06-29 Colabs International Corporation Compositions comprising silicon dioxide-based particles including one or more agents

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8507779D0 (en) * 1985-03-26 1985-05-01 Fujisawa Pharmaceutical Co Drug carrier
DE3636123A1 (de) * 1986-10-23 1988-05-05 Rentschler Arzneimittel Arzneizubereitungen zur oralen verabreichung, die als einzeldosis 10 bis 240 mg dihydropyridin enthalten
GB8629761D0 (en) * 1986-12-12 1987-01-21 Harris Pharma Ltd Capsules
KR920008948B1 (ko) * 1987-02-12 1992-10-12 니혼 덴네쯔 게이기 가부시끼가이샤 프린트 기판의 납땜방법 및 그의 장치
US5340591A (en) * 1992-01-24 1994-08-23 Fujisawa Pharmaceutical Co., Ltd. Method of producing a solid dispersion of the sparingly water-soluble drug, nilvadipine

Also Published As

Publication number Publication date
PT706380E (pt) 2002-02-28
CN1127990A (zh) 1996-07-31
ES2161768T3 (es) 2001-12-16
US5683716A (en) 1997-11-04
JPH09501150A (ja) 1997-02-04
EP0706380A1 (en) 1996-04-17
KR960703335A (ko) 1996-08-17
DE69427981D1 (de) 2001-09-20
EP0706380B1 (en) 2001-08-16
AU682192B2 (en) 1997-09-25
TW360543B (en) 1999-06-11
CN1087933C (zh) 2002-07-24
DE69427981T2 (de) 2001-11-29
DK0706380T3 (da) 2001-10-08
ATE204163T1 (de) 2001-09-15
WO1995001166A1 (en) 1995-01-12
AU6984294A (en) 1995-01-24
CA2165789A1 (en) 1995-01-12

Similar Documents

Publication Publication Date Title
GR3036407T3 (en) Encapsulated medicine
DE59609926D1 (de) Stabilisierte schilddrüsenhormonhaltige arzneimittel
AU1227899A (en) Osmotic medicament releasing system
HK1002017A1 (en) Lyospheres comprising gonadotropin
AU677279B2 (en) Application of carbamazepine and oxcarbazepine in the treatment of Parkinson's disease and Parkinsonian syndromes
WO2003011204A3 (en) Drug delivery systems
GEP20022752B (en) Valaciclovir Tablets Containing Colloidal Silicon Dioxide
KR960000217A (ko) L- 카르니틴염과 이를 함유한 조성물
DE69525649D1 (de) Lamotrigin haltiges arzneimittel
HUP9801414A2 (hu) Nátrium-alginátot és kálium-bikarbonátot tartalmazó folyékony vizes gyógyszerkészítmények
CA2350659A1 (en) Pharmaceutical composition for modified release insulin sensitiser
AU7775398A (en) Novel glycosylated ginkgolide derivatives, their application as medicines and pharmaceutical compositions
KR930702004A (ko) 세파로스포란 산 유도체를 함유하는 정제를 제조하기 위한 직접 압축 방법
PL308358A1 (en) Thylidine dihydroorthophosphate, method of obtaining same and pharmaceutical preparation containing that compound
DE59503283D1 (de) Carbamazepin-arzneiform mit verzögerter wirkstofffreisetzung
ATE207756T1 (de) Pharmazeutische zusammensetzung, die muirapuama und pflanzenwürmer enthaelt
HUT71491A (en) Tablet, capsule, or granule comprising desogestrel and process for preparation thereof
GR3019681T3 (en) 3- and 5-substituted 1,2,3,4-oxatriazole-5-imine compounds, a process for the preparation thereof, a pharmaceutical preparation containing said compounds and the use of said compounds for the preparation of medicaments.
RU95115409A (ru) Применение противосудорожных средств при лечении болезни паркинсона и синдромов паркинсона
UA11050C2 (uk) Спосіб лікуваhhя іhфаркту міокарда в гострому періоді
ITFI950120V0 (it) "contenitore distributore, specialmente per prodotti medicianali in compresse o capsule e simili".
IT1271354B (it) Preparazione di una forma farmaceutica atta a combattere l'iperinsulinismo contenente n-acetil cisteine e loro analoghi
JPH11171767A (ja) 睡眠剤

Legal Events

Date Code Title Description
ML Lapse due to non-payment of fees